Literature DB >> 15063586

Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery.

David J Brayden1, Alan W Baird.   

Abstract

Apical membrane-located receptors on intestinal Peyer's patch M cells have been identified as pathogen binding sites which have potential as targets for the delivery of formulated subunit and recombinant vaccine antigens. Gene expression studies have correlated outputs from a series of models including human intestinal M-like cell cultures and human Peyer's patch tissue. Outputs comprise novel receptors with unknown function and also conserved binding sites for an ever-increasing list of pathogens. Screening for ligands to mimic pathways used by selected pathogens for invading the human intestine has the potential for increasing the efficiency of delivery of oral vaccine antigens to M cells and consequently to sub-epithelial sites for antigen processing. Synthesis of efficient and specific targeting ligands to human M cells may eventually lead to formulations based on the formats of targeted antigen-loaded nanoparticles or ligand-conjugated stable antigens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063586     DOI: 10.1016/j.addr.2003.10.036

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  9 in total

Review 1.  Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?

Authors:  Roudayna Diab; Chiraz Jaafar-Maalej; Hatem Fessi; Philippe Maincent
Journal:  AAPS J       Date:  2012-07-06       Impact factor: 4.009

2.  Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  Matthew J Giacalone; Juan C Zapata; Neil L Berkley; Roger A Sabbadini; Yen-Lin Chu; Maria S Salvato; Kathleen L McGuire
Journal:  Vaccine       Date:  2006-12-26       Impact factor: 3.641

Review 3.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

Review 4.  Design opportunities for actively targeted nanoparticle vaccines.

Authors:  Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal:  Nanomedicine (Lond)       Date:  2008-06       Impact factor: 5.307

Review 5.  Roles of M cells in infection and mucosal vaccines.

Authors:  Miao Wang; Zeqian Gao; Zhongwang Zhang; Li Pan; Yongguang Zhang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 6.  Transepithelial antigen delivery in the small intestine: different paths, different outcomes.

Authors:  Kathryn A Knoop; Mark J Miller; Rodney D Newberry
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

Review 7.  Intestinal M cells: the fallible sentinels?

Authors:  Harvey Miller; Jianbing Zhang; Rhonda Kuolee; Girishchandra B Patel; Wangxue Chen
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 8.  Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials.

Authors:  Susann Bellmann; David Carlander; Alessio Fasano; Dragan Momcilovic; Joseph A Scimeca; W James Waldman; Lourdes Gombau; Lyubov Tsytsikova; Richard Canady; Dora I A Pereira; David E Lefebvre
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-01-30

Review 9.  Use of lectin-functionalized particles for oral immunotherapy.

Authors:  Susanne C Diesner; Xue-Yan Wang; Erika Jensen-Jarolim; Eva Untersmayr; Franz Gabor
Journal:  Ther Deliv       Date:  2012-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.